Enveric Biosciences, Inc. Balance Sheet
ENVB|3 years of annual SEC 10-K data (FY2017-FY2019)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 3 fiscal years. All figures from audited SEC 10-K filings.
Enveric Biosciences, Inc. had $30M in total assets and $19M in shareholders' equity as of FY2019.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2019 | FY2018 | FY2017 |
|---|---|---|---|
| Cash & Equivalents | $1.4M | $1.4M | $1.4M |
| Accounts Receivable | $7.9M | $7.9M | $8.8M |
| Current Assets | $10.1M | $10.1M | $14.6M |
| PP&E (Net) | $58.9K | $58.9K | $95.0K |
| Goodwill | $13.7M | $13.7M | $21.9M |
| Total Assets | $29.6M | $29.6M | $52.2M |
| Current Liabilities | $14.7M | $14.7M | $30.4M |
| Total Debt | - | - | $1.9M |
| Shareholders' Equity | $19.4M | - | $11.7M |